BeamMed Inc.

We develop, manufacture and market bone density assessment solutions. In particular, we lead the market with advanced ultrasound technology and devices that enable physicians to provide early assessment, diagnosis and monitoring of osteoporosis and to assess bone development. Thousands of our devices are in use in clinics, physician offices, research centers, hospitals, check-up centers and pharmacies around the world. Our devices are based on our patented Omnipath™ axial transmission technology, a quantitative ultrasound technology that has been proven as an effective screening tool for osteoporosis which improves HEDIS measures, allowing reaching 5-stars rating for HEDIS OMW. Measurement using our Omnisense and MiniOmni is reimbursed in the USA and other countries.